Treatment outcomes of advanced hepatocellular carcinoma in real‐life practice: Chemotherapy versus multikinase inhibitors

BACKGROUND: Multikinase inhibitors (MKIs) represent the main treatment options for advanced hepatocellular carcinoma (aHCC). However, accessibility in developing countries is limited. A chemotherapy, Fluorouracil and Oxaliplatin (FOLFOX), offers a less expensive treatment. Therefore, this study soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Oranratnachai, Songporn, Rattanasiri, Sasivimol, Sirachainan, Ekaphop, Tansawet, Amarit, Raunroadroong, Nilubol, McKay, Gareth J., Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939209/
https://www.ncbi.nlm.nih.gov/pubmed/36082831
http://dx.doi.org/10.1002/cam4.5224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939209/
https://www.ncbi.nlm.nih.gov/pubmed/36082831
http://dx.doi.org/10.1002/cam4.5224

Ejemplares similares